Disclosures: Dimple Desai: Nothing to Disclose, Rashmee Patil: Akero Therapeutics: Grant/Research Support, Altimmune: Grant/Research Support, 89Bio: Grant/Research Support, Boehringer Ingelheim: Grant/Research Support, Boston Pharmaceuticals: Grant/Research Support, Eli Lilly: Grant/Research Support, Helio Health: Grant/Research Support, Inventiva: Grant/Research Support, Madrigal Pharmaceuticals: Grant/Research Support, Madrigal Pharmaceuticals: Speaking and Teaching, Merck: Grant/Research Support, Novo Nordisk: Grant/Research Support, Novo Nordisk: Consultant, Galectin Therapeutics: Grant/Research Support, Hepion Pharmaceuticals: Grant/Research Support, GlaxoSmithKline: Grant/Research Support, Corcept Therapeutics: Grant/Research Support 1067 THE EFFECT OF DIET COMPOSITION EXPOSOME ON THE NATURAL HISTORY OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN THE MILLION VETERAN PROGRAM COHORT Lauren Callans 1 David Kaplan 2 Kerry Ivey 3 Kyong-Mi Chang 4 , 1 Perelman School of Medicine, University of Pennsylvania, 2 Perelman School of Medicine, 3 Harvard Medical School, 4 Corporal Michael J
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer
Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate
Additionally, it seeks to summarize potential avenues for future research, exploring various aspects of plant-pathogen interactions